ALLIQUA BIOMEDICAL INC's ticker is ALQA and the CUSIP is 019621200. A total of 44 filers reported holding ALLIQUA BIOMEDICAL INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $13,000 | +30.0% | 11,284 | -8.2% | 0.00% | – |
Q1 2016 | $10,000 | -86.3% | 12,292 | -63.9% | 0.00% | -100.0% |
Q4 2015 | $73,000 | -32.4% | 34,016 | 0.0% | 0.00% | -50.0% |
Q3 2015 | $108,000 | -39.7% | 34,016 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $179,000 | +1.1% | 34,016 | 0.0% | 0.01% | +20.0% |
Q1 2015 | $177,000 | -1.7% | 34,016 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $180,000 | – | 34,016 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PURA VIDA INVESTMENTS, LLC | 583,026 | $653,000 | 0.28% |
SUFFOLK CAPITAL MANAGEMENT LLC | 1,206,127 | $1,351,000 | 0.17% |
SABBY MANAGEMENT, LLC | 1,500,000 | $1,680,000 | 0.09% |
Tekla Capital Management LLC | 1,650,000 | $1,848,000 | 0.08% |
J. Goldman & Co LP | 540,000 | $605,000 | 0.03% |
Chicago Partners Investment Group LLC | 6,453 | $7,000 | 0.00% |
Edge Wealth Management LLC | 4,930 | $5,000 | 0.00% |
Acrospire Investment Management LLC | 2,400 | $3,000 | 0.00% |
US BANCORP \DE\ | 181,732 | $204,000 | 0.00% |
Renaissance Technologies | 271,500 | $304,000 | 0.00% |